-
Signature
-
Michael J. Farrell, Chief Executive Officer
-
Stock symbol
-
RMD
-
Transactions as of
-
May 7, 2024
-
Transactions value $
-
-$1,931,054
-
Form type
-
4
-
Date filed
-
5/9/2024, 11:58 AM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$99.9K |
+1.18K |
+0.27% |
$84.98 |
442K |
May 7, 2024 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$1.15M |
+13.5K |
+3.06% |
$84.98 |
455K |
May 7, 2024 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Sale |
-$3.18M |
-14.7K |
-3.22% |
$216.50 |
441K |
May 7, 2024 |
Direct |
F1, F2 |
| holding |
RMD |
ResMed Common Stock |
|
|
|
|
|
0 |
May 7, 2024 |
Lisette and Michael Farrell Foundation |
|
| holding |
RMD |
ResMed Common Stock |
|
|
|
|
|
4.09K |
May 7, 2024 |
Lisette and Michael Farrell Family Trust |
|
| holding |
RMD |
ResMed Common Stock |
|
|
|
|
|
0 |
May 7, 2024 |
Lisette & Michael Farrell Family Foundation |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-1.18K |
-1.14% |
$0.00 |
102K |
May 7, 2024 |
ResMed Common Stock |
1.18K |
$84.98 |
Direct |
F3 |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-13.5K |
-13.29% |
$0.00 |
88.1K |
May 7, 2024 |
ResMed Common Stock |
13.5K |
$84.98 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: